These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 2754711

  • 21. 125I-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptors.
    Linden J, Patel A, Earl CQ, Craig RH, Daluge SM.
    J Med Chem; 1988 Apr; 31(4):745-51. PubMed ID: 3351850
    [Abstract] [Full Text] [Related]

  • 22. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
    Sarges R, Howard HR, Browne RG, Lebel LA, Seymour PA, Koe BK.
    J Med Chem; 1990 Aug; 33(8):2240-54. PubMed ID: 2374150
    [Abstract] [Full Text] [Related]

  • 23. Selective activity of bamifylline on adenosine A1-receptors in rat brain.
    Abbracchio MP, Cattabeni F.
    Pharmacol Res Commun; 1987 Aug; 19(8):537-45. PubMed ID: 3432321
    [Abstract] [Full Text] [Related]

  • 24. 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.
    Daly JW, Padgett W, Shamim MT, Butts-Lamb P, Waters J.
    J Med Chem; 1985 Apr; 28(4):487-92. PubMed ID: 2984420
    [Abstract] [Full Text] [Related]

  • 25. N6,9-disubstituted adenines: potent, selective antagonists at the A1 adenosine receptor.
    Thompson RD, Secunda S, Daly JW, Olsson RA.
    J Med Chem; 1991 Sep; 34(9):2877-82. PubMed ID: 1895305
    [Abstract] [Full Text] [Related]

  • 26. N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors.
    Olsson RA, Kusachi S, Thompson RD, Ukena D, Padgett W, Daly JW.
    J Med Chem; 1986 Sep; 29(9):1683-9. PubMed ID: 3018244
    [Abstract] [Full Text] [Related]

  • 27. Electrophilic derivatives of purines as irreversible inhibitors of A1 adenosine receptors.
    Jacobson KA, Barone S, Kammula U, Stiles GL.
    J Med Chem; 1989 May; 32(5):1043-51. PubMed ID: 2709373
    [Abstract] [Full Text] [Related]

  • 28. Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance.
    Suzuki F, Shimada J, Shiozaki S, Ichikawa S, Ishii A, Nakamura J, Nonaka H, Kobayashi H, Fuse E.
    J Med Chem; 1993 Aug 20; 36(17):2508-18. PubMed ID: 8355252
    [Abstract] [Full Text] [Related]

  • 29. Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.
    Jiang J, van Rhee AM, Chang L, Patchornik A, Ji XD, Evans P, Melman N, Jacobson KA.
    J Med Chem; 1997 Aug 01; 40(16):2596-608. PubMed ID: 9258367
    [Abstract] [Full Text] [Related]

  • 30. High affinity acylating antagonists for the A1 adenosine receptor: identification of binding subunit.
    Stiles GL, Jacobson KA.
    Mol Pharmacol; 1988 Dec 01; 34(6):724-8. PubMed ID: 3200248
    [Abstract] [Full Text] [Related]

  • 31. Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives.
    Kim HO, Ji XD, Melman N, Olah ME, Stiles GL, Jacobson KA.
    J Med Chem; 1994 Nov 11; 37(23):4020-30. PubMed ID: 7966162
    [Abstract] [Full Text] [Related]

  • 32. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG, Tabrizi MA, Preti D, Bovero A, Romagnoli R, Fruttarolo F, Zaid NA, Moorman AR, Varani K, Gessi S, Merighi S, Borea PA.
    J Med Chem; 2004 Mar 11; 47(6):1434-47. PubMed ID: 14998332
    [Abstract] [Full Text] [Related]

  • 33. Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors.
    Ukena D, Jacobson KA, Padgett WL, Ayala C, Shamim MT, Kirk KL, Olsson RO, Daly JW.
    FEBS Lett; 1986 Dec 01; 209(1):122-8. PubMed ID: 3803571
    [Abstract] [Full Text] [Related]

  • 34. Substituted 1,3-dipropylxanthines as irreversible antagonists of A1 adenosine receptors.
    Scammells PJ, Baker SP, Belardinelli L, Olsson RA.
    J Med Chem; 1994 Aug 19; 37(17):2704-12. PubMed ID: 8064798
    [Abstract] [Full Text] [Related]

  • 35. Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.
    Kim YC, Ji X, Melman N, Linden J, Jacobson KA.
    J Med Chem; 2000 Mar 23; 43(6):1165-72. PubMed ID: 10737749
    [Abstract] [Full Text] [Related]

  • 36. 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX)--a selective high affinity antagonist radioligand for A1 adenosine receptors.
    Lohse MJ, Klotz KN, Lindenborn-Fotinos J, Reddington M, Schwabe U, Olsson RA.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Aug 23; 336(2):204-10. PubMed ID: 2825043
    [Abstract] [Full Text] [Related]

  • 37. Apparent affinity of some 8-phenyl-substituted xanthines at adenosine receptors in guinea-pig aorta and atria.
    Collis MG, Jacobson KA, Tomkins DM.
    Br J Pharmacol; 1987 Sep 23; 92(1):69-75. PubMed ID: 3664093
    [Abstract] [Full Text] [Related]

  • 38. Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptors.
    Thompson RD, Secunda S, Daly JW, Olsson RA.
    J Med Chem; 1991 Dec 23; 34(12):3388-90. PubMed ID: 1766003
    [Abstract] [Full Text] [Related]

  • 39. Linear and proximal benzo-separated alkylated xanthines as adenosine-receptor antagonists.
    Schneller SW, Ibay AC, Christ WJ, Bruns RF.
    J Med Chem; 1989 Oct 23; 32(10):2247-54. PubMed ID: 2795597
    [Abstract] [Full Text] [Related]

  • 40. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
    Hayallah AM, Sandoval-Ramírez J, Reith U, Schobert U, Preiss B, Schumacher B, Daly JW, Müller CE.
    J Med Chem; 2002 Mar 28; 45(7):1500-10. PubMed ID: 11906291
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.